Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.07 USD | -1.78% | -4.23% | -2.50% |
09:58am | GSK: decisions in the Zantac (ranitidine) litigation | CF |
08:53am | GSK Appeals US Judge's Decision to Allow Plaintiff Expert Testimony in Zantac Litigation | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,777 PTS | -0.20% | -0.38% | - | ||
28.07 USD | -1.78% | -4.23% | 159B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.50% | 159B | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+19.38% | 249B | |
-1.47% | 216B | |
+11.91% | 214B | |
+5.80% | 163B | |
+1.89% | 121B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs